Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 1

1(33.3%)

Phase 2

1(33.3%)

N/A

1(33.3%)

3Total

Phase 1(1)

Phase 2(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07366905Phase 2Not Yet Recruiting

Clinical Observation of Bupivacaine Liposome for Lower Extremity Nerve Block

Role: lead

NCT07124949Recruiting

Chinese Migrant Population Health Cohort

Role: collaborator

NCT06751381Not Yet Recruiting

Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal Radiomics

Role: lead

NCT06686186Recruiting

Hainan Community Cognition Cohort

Role: lead

NCT03926325Unknown

Baseline Investigation of Patients With Cardiac Arrest in China

Role: collaborator

NCT03288805Active Not Recruiting

Cohort Study in South China

Role: collaborator

NCT02998242Not ApplicableCompleted

Apatinib in Combination With Stereotactic Body Radiation Therapy (SBRT) Treatment for Symptomatic Metastatic Prostate Cancer

Role: collaborator

NCT01029496Phase 1Unknown

Immediate VS Delayed Cord Clamping on Newborns

Role: lead

All 8 trials loaded